Hypothermic storage with University of Wisconsin solution preserves endothelial and vascular smooth-muscle function

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Sorajja, Paul ^a   Cable, David G ^a   Schaff, Hartzell V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Coronary artery; Endothelium; Nitric oxide; Transplantation

Indexed keywords

ACETYLCHOLINE; CALCIMYCIN; METHYLENE BLUE; N METHYLACETAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY; DOG; HEART PRESERVATION; HEART TRANSPLANTATION; INDUCED HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

ADENOSINE; ALLOPURINOL; ANIMALS; COLD; CORONARY VESSELS; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; GLUTATHIONE; GUANYLATE CYCLASE; INSULIN; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE;

EID: 0343144802     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Jamieson NV, Sundberg R, Lindell S, Laravuso R, Kalayoglu M, Southard JH, Belzer FO. Successful 24- to 30-hour preservation of the canine liver: a preliminary report. Transplant Proc. 1988; 20(suppl I):945-947.
2. Wahlberg JA, Love R, Landegaard L, Southard JH, Beizer FO. 72-Hour preservation of the canine pancreas. Transplantation. 1987;43:5-8.
3. Ploeg RJ, Goossens D, Vreugdenhil P, McAnulty JF, Southard JH, Beizer FO. Successful 72-hour cold storage kidney preservation with UW solution. Transplant Proc. 1988;20(suppl I):935-938.
4. Mankad PS, Chester AH, Yacoub MH. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg. 1991;51:89-93.
5. Ekin ST, Pearson PJ, Evora PR, Schaff HV. One-hour exposure to University of Wisconsin solution does not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries. J Heart Lung Transplant. 1993;12:624-633.
6. Lin PJ, Chang CH, Yao PC, Hsieh HC, Hsieh MJ, Kao CL, Tsai KT. Enhancement of endothelium-dependent contraction of the canine coronary artery by UW solution. Transplantation. 1994;58: 1323-1328.
7. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987;92:639-646.
8. Pearson PJ, Schaff HV, Vanhoutte PM. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res. 1990;67: 385-393.
9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
10. Lambert TL, Kent RS, Whorton AR. Bradykinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells. J Biol Chem. 1986;261:15288-15293.
11. Seccombe JF, Schaff HV. Vasoactive Factors Produced by the Endothelium: Physiology and Surgical Implications. Austin, Tex: RG Landes; 1994:10.
12. Yang ZH, von Segesser L, Bauer E, Stulz P, Turina M, Luscher TF. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res. 1991;68:52-60.
13. Kojda G, Noack E. Nitric oxide liberating, soluble guanylate cyclase stimulating and vasorelaxing properties of the new nitrate-compound SPM 3672. J Cardiovasc Pharm. 1993;22:103-111.
14. Rees DD, Palmer RM, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
15. Mayer B, Brunner F, Schmidt K. Novel actions of methylene blue. Eur Heart J. 1993;14(suppl I):22-26.
16. Lüscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang Z, Turina M, Grädel E, Weber E, Bühler FR. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 1988;319: 462-467.
17. Drinkwater DC Jr, Ziv ET, Laks H, Lee JR, Bhuta S, Rudis E, Chang P. Extracellular and standard University of Wisconsin solutions provide equivalent preservation of myocardial function. J Thorac Cardiovasc Surg. 1995;110:738-745.
18. Molina JE, Galliani CA, Einzig S, Bianco R, Rasmussen T, Clack R. Physical and mechanical effects of cardioplegic injection on flow distribution and myocardial damage in hearts with normal coronary arteries. J Thorac Cardiovasc Surg. 1989;97:870-877.
19. Kontos HA, Wei EP. Reversal of acetylcholine-induced cerebral vasodilation after acute hypertension. Microvasc Res. 1985;29: 231-232. Abstract.
20. Cartier R, Pellerin M, Hollmann C, Pelletier LC. Effects of pressure and duration of hyperkalemic infusions on endothelial function. Ann Thorac Surg. 1993;55:700-705.
21. Evora PR, Pearson PJ, Schaff HV. Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries. J Thorac Cardiovasc Surg. 1992;104:1365-1374.
22. Ingemansson R, Sjöberg T, Massa G, Steen S. Long-term preservation of vascular endothelium and smooth muscle. Ann Thorac Surg. 1995;59:1177-1181.
23. Fremes SE, Li R-K, Weisel RD, Mickle DAG, Tumiati LC. Prolonged hypothermie cardiac storage with University of Wisconsin solution: an assessment with human cell cultures. J Thorac Cardiovasc Surg. 1991;102:666-672.
24. Eberl T, Schmid T, Hengster P, Wodlinger R, Oberhuber G, Weiss H, Herold M, Waldenberger F, Margreiter R. Protective effects of various preservation solutions on cultured endothelial cells. Ann Thorac Surg. 1994;58:489-495.
25. Swanson DK, Pasaoglu I, Berkoff HA, Southard JA, Hegge JO. Improved heart preservation with UW preservation solution. J Heart Transplant. 1988;7:456-467.
26. Fremes SE, Li R-K, Weisel RD, Mickle DAG, Tumiati LC. Improved hypothermie storage with University of Wisconsin solution. Surg Forum. 1989;40:246-248.
27. Jeevanandam V, Auteri JS, Barr ML, Ott G, Sanchez JA, Smith CR, Rose EA. Improved heart preservation with University of Wisconsin solution: experimental and preliminary human experience. Circulation. 1990;82(suppl III):III-256. Abstract.
28. Jeevanandam V, Barr ML, Auteri JS, Sanchez JA, Fong J, Schenkel FA, Marboe CC, Michler RE, Smith CR, Rose EA. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation: a randomized blinded prospective clinical trial. J Thorac Cardiovasc Surg. 1992;103:194-198.
29. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
30. Zilla P, von Oppell U, Deutsch M. The endothelium: a key to the future. J Cardiovasc Surg. 1993;8:32-60.
31. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant. 1992;11:9-23.
32. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987;76:827-834.
33. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
34. Amezcua JL, Palmer RM, de Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol. 1989;97:1119-1124.
35. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 1993;88:43-54.
36. Lefer AM, Ma XL, Weyrich A, Lefer DJ. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl. 1993;41:127-135.
37. Beresewicz A, Wozniak M. Mechanical performance and coronary flow adjustments to changes in workload are not affected by inhibiting nitric oxide production in isolated working rat heart. Pol J Pharmacol. 1993;45:533-548.
38. Yamamoto K, Masuyama T, Mano T, Naito J, Kondo H, Nagano R, Tanouchi J, Hori M, Kamada T. Basal release of endothelium-derived nitric oxide plays an important role in the prevention of afterload mismatch in acute left ventricular dysfunction. Angiology. 1995;46:767-777.
39. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995;92:320-326.